Avid Bioservices Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	0.56	127.67	3.32	-15.15	-8.9	-26.5	-32.8	-60.14	-54.05	-35.76	Upgrade
Depreciation & Amortization	7.21	4.48	3.45	3.09	2.75	2.56	2.46	1.54	1.04	0.99	Upgrade
Share-Based Compensation	10.98	7.38	3.85	2.5	1.6	1.54	3.36	4.9	6.7	6.21	Upgrade
Other Operating Activities	-31.64	-130.07	12.66	10.7	-11.72	-8.28	-16.84	9.63	6.6	-0.09	Upgrade
Operating Cash Flow	-12.89	9.47	31.18	5.83	-11.6	-25.99	-39.17	-39.59	-36.02	-28.25	Upgrade
Operating Cash Flow Growth	-	-69.65%	435.13%	-	-	-	-	-	-	-	Upgrade
Capital Expenditures	-77.64	-56.41	-9.86	-3.81	4.54	-0.79	-3.63	-8.88	-9.05	-0.76	Upgrade
Other Investing Activities	-	-	-	-	-	-	0.57	0.09	0.6	-1.77	Upgrade
Investing Cash Flow	-77.64	-56.41	-9.86	-3.81	4.54	-0.79	-3.06	-8.79	-8.45	-2.52	Upgrade
Share Issuance / Repurchase	3.41	3.36	36.13	1.12	1.54	26.76	31.01	45.87	20.14	55.41	Upgrade
Debt Issued / Paid	-0.51	-0.16	121.16	4.3	-0.07	-0.18	-0.14	0	-0.01	-0.03	Upgrade
Other Financing Activities	-	-	-44.95	-4.33	-4.33	-4.33	-2.7	-4.08	14.85	17.69	Upgrade
Financing Cash Flow	2.9	3.2	112.34	1.1	-2.86	22.25	28.17	41.79	34.98	73.06	Upgrade
Net Cash Flow	-87.62	-43.75	133.65	3.11	-9.91	-4.53	-14.06	-6.59	-9.49	42.29	Upgrade
Free Cash Flow	-90.53	-46.95	21.32	2.02	-7.05	-26.79	-42.8	-48.47	-45.07	-29.01	Upgrade
Free Cash Flow Growth	-	-	957.97%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-60.65%	-39.25%	22.24%	3.38%	-13.15%	-49.95%	-74.26%	-109.27%	-168.28%	-129.50%	Upgrade
Free Cash Flow Per Share	-1.45	-0.76	0.37	0.04	-0.13	-0.57	-1.15	-1.57	-1.73	-1.26	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).